Related references
Note: Only part of the references are listed.Current updates on precision therapy for breast cancer associated brain metastasis: Emphasis on combination therapy
Masoom Raza et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2021)
A Phase I Study of Alpha-1,3-Galactosyltransferase-Expressing Allogeneic Renal Cell Carcinoma Immunotherapy in Patients with Refractory Metastatic Renal Cell Carcinoma
Andrew W. Hahn et al.
ONCOLOGIST (2020)
Molecular Chaperones in Cancer Stem Cells: Determinants of Stemness and Potential Targets for Antitumor Therapy
Alexander Kabakov et al.
CELLS (2020)
Amalgamation of PI3K and EZH2 blockade synergistically regulates invasion and angiogenesis: combination therapy for glioblastoma multiforme
Vishnu S. Mishra et al.
Oncotarget (2020)
Upregulation of HIF1-α via an NF-κB/COX2 pathway confers proliferative dominance of HER2-negative ductal carcinoma in situ cells in response to inflammatory stimuli
Dominika Piasecka et al.
NEOPLASIA (2020)
Clinical Benefit of Sorafenib Combined with Paclitaxel and Carboplatin to a Patient with Metastatic Chemotherapy-Refractory Testicular Tumors
Bijun Lian et al.
ONCOLOGIST (2019)
Drug repurposing for Alzheimer's disease based on transcriptional profiling of human iPSC-derived cortical neurons
Gareth Williams et al.
TRANSLATIONAL PSYCHIATRY (2019)
A phase II study of pembrolizumab and paclitaxel in patients with relapsed or refractory small-cell lung cancer
Yu-Jung Kim et al.
LUNG CANCER (2019)
Stable Dispersions of Covalently Tethered Polymer Improved Graphene Oxide Nanoconjugates as an Effective Vector for siRNA Delivery
Nisha Yadav et al.
ACS APPLIED MATERIALS & INTERFACES (2018)
Triple negative breast cancer: Emerging therapeutic modalities and novel combination therapies
Alice Lee et al.
CANCER TREATMENT REVIEWS (2018)
cAMP regulated EPAC1 supports microvascular density, angiogenic and metastatic properties in a model of triple negative breast cancer
Naveen Kumar et al.
CARCINOGENESIS (2018)
Insights into exchange factor directly activated by cAMP (EPAC) as potential target for cancer treatment
Naveen Kumar et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2018)
Downregulation of occludin affects the proliferation, apoptosis and metastatic properties of human lung carcinoma
Meifang Wang et al.
ONCOLOGY REPORTS (2018)
Perspectives on the role of brain cellular players in cancer-associated brain metastasis: translational approach to understand molecular mechanism of tumor progression
Masoom Raza et al.
CANCER AND METASTASIS REVIEWS (2018)
A phase II study of tivozanib in patients with metastatic and nonresectable soft-tissue sarcomas
M. Agulnik et al.
ANNALS OF ONCOLOGY (2017)
Phase II study of tivozanib, an oral VEGFR inhibitor, in patients with recurrent glioblastoma
Jayashree Kalpathy-Cramer et al.
JOURNAL OF NEURO-ONCOLOGY (2017)
MENA Confers Resistance to Paclitaxel in Triple-Negative Breast Cancer
Madeleine J. Oudin et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Drug repurposing for the treatment of glioblastoma multiforme
Claudia Abbruzzese et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
Role of exchange protein directly activated by cAMP (EPAC1) in breast cancer cell migration and apoptosis
Naveen Kumar et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2017)
Drug repositioning of mevalonate pathway inhibitors as antitumor agents for ovarian cancer
Yusuke Kobayashi et al.
ONCOTARGET (2017)
Pharmacological approach for drug repositioning against cardiorenal diseases
Yoshito Zamami et al.
JOURNAL OF MEDICAL INVESTIGATION (2017)
AKAP-9 promotes colorectal cancer development by regulating Cdc42 interacting protein 4
Zhi-Yan Hu et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2016)
BATON-CRC: A Phase II Randomized Trial Comparing Tivozanib Plus mFOLFOX6 with Bevacizumab Plus mFOLFOX6 in Stage IV Metastatic Colorectal Cancer
Al B. Benson et al.
CLINICAL CANCER RESEARCH (2016)
Fluvoxamine, an anti-depressant, inhibits human glioblastoma invasion by disrupting actin polymerization
Keiichiro Hayashi et al.
SCIENTIFIC REPORTS (2016)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Loss of GM130 in breast cancer cells and its effects on cell migration, invasion and polarity
Francesco Baschieri et al.
CELL CYCLE (2015)
βIII-Tubulin Regulates Breast Cancer Metastases to the Brain
Deepak Kanojia et al.
MOLECULAR CANCER THERAPEUTICS (2015)
α-Tubulin Acetylation Elevated in Metastatic and Basal-like Breast Cancer Cells Promotes Microtentacle Formation, Adhesion, and Invasive Migration
Amanda E. Boggs et al.
CANCER RESEARCH (2015)
Recent Advances in Drug Repositioning for the Discovery of New Anticancer Drugs
Joong Sup Shim et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2014)
Breast-Conserving Therapy for Triple-Negative Breast Cancer
Alexandra Gangi et al.
JAMA SURGERY (2014)
Development of Therapeutic Combinations Targeting Major Cancer Signaling Pathways
Timothy A. Yap et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Occludin Is Involved in Adhesion, Apoptosis, Differentiation and Ca2+-Homeostasis of Human Keratinocytes: Implications for Tumorigenesis
Susanne Rachow et al.
PLOS ONE (2013)
The DNA binding and accumulation of p53 from breast cancer cell lines and the link with serine 15 phosphorylation
Debolina Ray et al.
CANCER BIOLOGY & THERAPY (2012)
Tivozanib: current status and future directions in the treatment of solid tumors
Sumanta K. Pal et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2012)
AKAP9 regulation of microtubule dynamics promotes Epac1-induced endothelial barrier properties
Seema Sehrawat et al.
BLOOD (2011)
Loss of occludin leads to the progression of human breast cancer
Tracey A. Martin et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2010)
Gemcitabine plus paclitaxel versus paclitaxel monotherapy in patients with metastatic breast cancer and prior anthracycline treatment
Kathy S. Albain et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Pilot study: Fluvoxamine treatment for depression and anxiety disorders in children and adolescents with cancer
D Gothelf et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2005)
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
HE Bryant et al.
NATURE (2005)
IL-1β mediated up-regulation of HIF-1α via an NFkB/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis
YJ Jung et al.
FASEB JOURNAL (2003)
Breast and ovarian cancer
R Wooster et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)